Introduction
The study of proteins and transmembrane interactions is in the forefront of scientific research because of the intricate role membrane proteins play in many cellular processes like cell signaling and the opening and closing of voltage-gated channels (1) . In our lab, we use synthetic model peptides ("GWALP" families; see Table 1 ) to analyze the intricate relationship between peptides and lipid bilayers. The GWALP peptides arose from an original WALP model peptide which contained four aromatic residues that served as anchors for a membrane-spanning helix (3)(8) (14) . Additionally, the length of the hydrophobic core of the WALP peptide was altered and analyzed with various lengths of phosphatidylcholine lipids to study hydrophobic mismatch in WALP peptides and lipid interactions. Though useful for studying peptide mismatch, the WALP peptides were highly dynamic and were not good model peptides to analyze the effects of altering a single residue on the peptide (17) .
The GWALP23 model peptide, a cognate of the WALP peptide, was developed to reduce the high dynamics that was seen in the WALP model peptide. The GWALP23 model peptide consists of two anchoring tryptophan (Trp/W) residues instead of the initial four, which (remarkably) allows for greater stability and lower dynamics of the transmembrane helix (15)(16). GWALP23 (GGALW(LA)6LWLAGA) contains one tryptophan residue on each end (at positions 5 and 19), and a repeating leucine-alanine helical core sequence (5) (10). The repeating leucine-alanine helical core prefers the hydrophobic environment of the membrane, whereas the Trp residues prefer a location near the lipid-water interface (11) . The leucine-alanine core accentuates the peptide's response to the thickness of the membrane (that is a result of hydrophobic mismatch).
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This hydrophobic mismatch is from the difference between the thickness of the lipid bilayer's hydrophobic portion and the length of the peptide's hydrophobic core. The mismatch can affect both the orientation of the peptide in the lipid bilayer and the alignment of the lipid themselves (8) . This sensitivity of the GWALP23 peptide makes it the preferred model for studying the influence of single and multiple residue replacements on peptide orientation and dynamics. The orientation and dynamics of GWALP23 and a tyrosine derivative (containing Y 5 instead of W 5 ) are well understood (5) . In this project, the GWALP23 peptide was modified by adding a central tryptophan in the 12 th or 13 th position in the hydrophobic core of the GWALP23 peptide. Alanine residues in the helical core were labeled with deuterium in order to study the dynamics and orientation of the peptide in lipid bilayers by solid-state deuterium NMR. Depending on the intent of the study, alanine can be labeled either in the core positions of 7 and 9, 11 and 13, 15 and 17, or in the end positions of 3 and 21. In the alanine pairs that are labeled, the alanine closer to the N-9 terminal is labeled with 50% deuterated alanine and the other alanine is labeled with 100% deuterated alanine.
Figure 2:
The GWALP23-W12 is shown on the left and GWALP23-W13 is shown on the right
The orientations of GWALP23-W12 and GWALP23-W13 were investigated in bilayers of DLPC (12:0), DMPC (14:0), and DOPC (18:1). It can be hypothesized that the indole ring of all tryptophans, including the central W12 or W13, will prefer the membrane-water interface. Results for GWALP23-W12 and GWALP23-W13 will be compared to those of GWALP23 to observe the changes that have occurred in peptide orientation (specifically the helix tilt and rotation).
In addition to studying the effects of a central tryptophan, the effects of altering the aromatic anchors on a GWALP23 are also studied. Table 1 below. 
Materials and Methods

Solid Phase Peptide Synthesis with 2 H Labels
Peptides with deuterium labeled alanines were synthesized using an applied Biosystems 433A Peptide Synthesizer (7). The Fmoc-ala-d4 was made by members in the lab as described in (5) . For the amino acids that comprise the peptide, 0.57 mmoles of the amino acid was weighed out and placed in separate cartridges. The peptide was labeled with two deuterium labeled alanines (one 50% labeled and one 100% labeled) at the core of the peptide at positions 7 and 9, 11 and 13, 15 and 17, or the ends of the peptide at position 3 and 21. For the labeled alanines, 0.28 mmoles of Fmoc-Ala-d4 with 0.28 mmoles of Alanine were placed in a cartridge (for the 50% deuterium labeled Alanine). 0.57 mmoles of only fmoc-Ala-d4 was used for the 100% deuterium labeled
Alanine. The peptide was synthesized from the carboxy end of a Wang resin (company), achieved by ordering the cartridges from the C to N-terminal. During the synthesis, the "FastMoc" method was used on the synthesizer and a series of deprotecting, coupling, and rinsing was performed (6) .
Cleavage of the Peptide:
After the completion of the peptide synthesis, the peptide is cleaved from the resin with Ethanolamine. The resin with the peptide is placed in a glass vial and 11 mL of Dichloromethane and 4 mL of Ethanolamine is added to the resin. The glass vial is wrapped in foil and placed on a shaker for 48 hours at 480 min-1. After the 48 hours, the resin slurry is filtered with a 10mL glass filter. The resin solution is rinsed with 5mL of Dichloromethane four times and then 5 mL of TFE four times. After the rinse, the rotovap is set up and used to minimize the volume of the filtered liquid. After rotovaping, the resulting peptide substance is equally poured into two centrifuge tubes and filled with DI H20 (about 80% of the total volume of the centrifuge tube should be DI water). The 14 tubes are placed in a refrigerator and allowed to precipiate in DI water overnight. The next day, the JA-20 rotor is used to centrifuge the peptide mixture at 14,000 RPM for two hours. The resulting supernatant should be disposed and the pellet should be dried on the vacuum line overnight.
Crude GWALP Quantitation and Purification:
After the peptide has been cleaved off of the resin, the amount of peptide that has been recovered needs to be determined. This process is called peptide quantitation. To quantitate the peptide, 0.5 mL of TFE is added into the centrifuge tubes with the dried peptide. A UV-Vis sample is prepared by mixing 2 L of the dried peptide with 1.5 mL of Methanol. The UV-Vis is blanked with methanol and the sample is run at 280 nm. The resulting spectra and the optical density (at 280nm), allows for the calculation of the total milligrams of peptide that is present. To test the peptide, analytical HPLC is run with a 1L aliquot of the peptide solution (diluted to 1mg/ml with TFE). The sample is then prepped for mass spectrometry with 50 L of the peptide is diluted with 450 L of TFE.
After the peptide cleavage, the peptide is ready to purify using the Semi-prep HPLC.
Reverse-Phase High Performance Liquid Chromatography (RP-HPLC) with the Hitachi L1700 system and the Zorbax RX-C8 column, 9.4 mm x 250mm ( Agilent Technology).
The HPLC machine is first purged and a desired gradient is set at 95-99% for the GWALP23 with an extra tryptophan. A test injection of 10 L is initially injected to determine the approximate peak position (time the peptide will come off the machine).
After the test injection, the range of the RP-HPLC is set to 10 and a 500L aliquot of the peptide is injected. The purified product is usually collected after 23-25 minutes and then dried. Finally, the purified peptide is quantitated to determine how much pure peptide (in milligrams) is collected. For this, the peptide is redissolved in 1 mL of TFE and a UV-Vis sample is made with 10 L of the peptide and 990L of MeOH. Again, from the Optical Density at 28nm, the weight of the total peptide (in mg) can be calculated. After rechecking the peptide wih MALDI-TOF mass spectrometry with a 50 L aliquot o the peptide and 450 L of TFE), the peptide is aliquoted for solid-state 2 
Mass Spectrometry
The mass of the mass spectrometry spectra, allows for the verification of our intended peptide by comparing expected and actual mass of peptide. The molecular mass of the peptide was confirmed by MALDI-TOF mass spectrometry (MS) MALDI run by the University of Arkansas-Arkansas Statewide Mass spectrometry. The satellite peaks that are observed represent the different ionization states of the peptide. As described, peptides can also be purified using the semi-preparative HPLC to eliminate miscellaneous substances.
Circular Dichroism Spectroscopy
When working with peptides, it is important to know the structural conformation (ver. 1.6. SP7). While samples were running, they were excited at 280 nm (the excitation wavelength for Trp) and the emission was recorded at 300 to 450nm. The emission measurement is scanned at a rate of 60nm/min with 5mm excitation and emission slit widths. The excitation pathlength was 10nm and the emission path length was 1nm.
Oriented Sample Preparation:
Oriented Samples made for NMR spectroscopy were prepared in a 1:40 peptide to lipid ratio using DLPC, DMPC, and DOPC lipid membranes. L of deuterium depleted water. The water (about 3-4 drops per plate) was used as the 'glue' to stack the 40 glass plates. Once the plates were stacked, they were inserted into a cuvette. The, empty glass plates were then added to the outside of the stack to fill the cuvette. Finally, the cuvette was sealed with a glass square cover using epoxy glue. Once the cuvette was sealed twice (with one hour between the first and second seal), the plates was placed inside a dark, heating plate at 40 C for several days (until sample looks clear). 3a.
3b.
4.
β=0° β=90°
A type of NMR called, 31 P NMR spectroscopy is used to verify bilayer alignment.
The sample was run at 50 ºC on a Bruker Avance 300 spectrometer (Billerica, MA) in both β=0° orientation (where the bilayer is parallel to the applied magnetic field) and β=90º orientation (where the bilayer is perpendicular to the applied magnetic field).
H NMR:
Similar to 31 P NMR, solid-state 2 H NMR at 50 °C on a Bruker Avance 300
spectrometer. The samples were run at β=0° and β=90°. The resulting spectrum gives information about quadrupolar splitting that will serve useful in creating a tilt analysis to study the behavior of the peptides in various lipids.
Tilt Analysis:
From the 2 H quadrupolar splittings (Δνq) that was collected in various lipids (DLPC, DMPC, DOPC) with different set of alanines labels, the orientation of the peptide in the lipid bilayers was determined. Two methods of calculations, GALA fit and modified
Gaussian were used to perform a semistatic model with variable parameters. The parameters for the calculations are the tilt of helix τ, helix rotation ρ, and Szz, a principal order parameter. This principal order parameter gives more information about the overall motion of the peptide relative to the orientation of the peptide.
Results
After the target peptides were synthesized and purified, their molecular masses were confirmed by MALDI-TOF mass spectrometry. From the resulting mass spectrum, the expected mass of (2378 + 8 for the deuterons + 23 for sodium) can be compared with the actual mass of 2408.4 as shown on the spectrum.
[M + Na] + 2408.4 After verification that the desired peptide had been synthesized, an estimate of the secondary structure of the peptide was assessed using circular dichroism (CD) spectroscopy. The repeating Leu-Ala sequence in the core of the GWALP23 peptides prefers an alpha-helical secondary structure that is in the hydrophobic region of the lipid bilayer. 
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DLPC DMPC DOPC Table 5 , it can be concluded that F 4,5 GWALP23 nevertheless seems to tilt to a slightly greater degree or tends to be less dynamic than W 4,5 GWALP23.
The reason for the small difference is unknown but could relate to the differing properties of the different Phe and Trp aromatic rings.
In addition, from Tables 3, 4, In tables 6 and7, the tilt () and rotation () can be compared between the peptides with a central tryptophan and the regular GWALP23 peptide. The GALA Fit method shows the tilt for GWALP23 to be 20.7°, the tilt for GWALP23-W12 to be 17.0° and the tilt for GWALP23-W13 to be 18.7°. All the values for tilt, regardless of the type of peptide, seem to have tilt values very similar to each other (between 17-21). Similarly, in the modified Gaussian method, the rotation for GWALP23 is calculated to be 304° and the rotation for GWALP23-W12 is 326°. The rotation, like the tilt, does not differ much between peptides in DLPC lipid bilayers. In DOPC, the GALA fit method calculates the tilt to be 6° for GWALP23 and 6.7° for GWALP23-W12. The modified Gaussian determines the rotation to be 321° for GWALP23 and 330° for GWALP23-W12. Both the tilt and rotation of the peptide stay pretty consistent in DOPC regardless of the presence of a central tryptophan.
It can be concluded from GALA fit and modified Gaussian tilt analysis in DLPC, DMPC, and DOPC that the orientation of the peptide is largely unaffected by a central tryptophan. Nevertheless, I have observed that the samples are more difficult to make and the NMR signal-to-noise ratio is less when a central tryptophan is present in the peptide helix.
In addition to studying the orientation and behavior of peptides with a central tryptophan, it is also a point of interest to study the possibility of 'ends-fraying' of peptide helices with a central tryptophan. The possible fraying near the ends of helices of GWALP23-W12 or GWALP23-W13 could lead to stabilization of the helix in the membrane. To investigate the ends, deuterium labels were incorporated in residues A 
